Comerica Bank
AMED

Comerica Bank’s Amedisys AMED Stock Holding History

Comerica Bank’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,202
Closed -$905K – 3714
2025
Q2 		$905K Sell
9,202
-179
-2% -$16.9K ﹤0.01% 1579
2025
Q1 		$869K Sell
9,381
-161
-2% -$14.8K ﹤0.01% 1580
2024
Q4 		$866K Sell
9,542
-782
-8% -$71.8K ﹤0.01% 1633
2024
Q3 		$996K Sell
10,324
-1,763
-15% -$172K ﹤0.01% 1541
2024
Q2 		$1.11M Sell
12,087
-1,111
-8% -$103K ﹤0.01% 1434
2024
Q1 		$1.22M Sell
13,198
-555
-4% -$52K 0.01% 1438
2023
Q4 		$1.31M Buy
13,753
+92
+0.7% +$8.59K 0.01% 1394
2023
Q3 		$1.28M Sell
13,661
-3,963
-22% -$366K 0.01% 1306
2023
Q2 		$1 Buy
+17,624
New +$1.45M ﹤0.01% 622
2022
Q4 		$1.24M Sell
14,477
-597
-4% -$53.8K 0.01% 1344
2022
Q3 		$1.48M Sell
15,074
-307
-2% -$36.6K 0.01% 1246
2022
Q2 		$1.93M Sell
15,381
-119
-0.8% -$15.2K 0.02% 1127
2022
Q1 		$2.35M Buy
15,500
+345
+2% +$51.5K 0.02% 1063
2021
Q4 		$2.02M Sell
15,155
-335
-2% -$53.8K 0.01% 1142
2021
Q3 		$2.62M Sell
15,490
-3,162
-17% -$657K 0.02% 1117
2021
Q2 		$3.33M Sell
18,652
-330
-2% -$86.6K 0.02% 972
2021
Q1 		$5.4M Sell
18,982
-3,977
-17% -$1.12M 0.03% 698
2020
Q4 		$7.2M Sell
22,959
-439
-2% -$113K 0.05% 478
2020
Q3 		$5.88M Sell
23,398
-3,546
-13% -$806K 0.04% 493
2020
Q2 		$5.79M Buy
26,944
+483
+2% +$90.1K 0.04% 449
2020
Q1 		$4.93M Sell
26,461
-570
-2% -$101K 0.05% 422
2019
Q4 		$4.94M Sell
27,031
-176
-0.6% -$26.2K 0.04% 545
2019
Q3 		$3.63M Buy
27,207
+1,620
+6% +$211K 0.03% 682
2019
Q2 		$3.23M Sell
25,587
-1,215
-5% -$144K 0.03% 765
2019
Q1 		$3.43M Sell
26,802
-9,084
-25% -$1.14M 0.03% 748
2018
Q4 		$4.58M Buy
35,886
+195
+0.5% +$23K 0.04% 546
2018
Q3 		$3.89M Buy
35,691
+5,481
+18% +$605K 0.03% 667
2018
Q2 		$2.82M Buy
30,210
+206
+0.7% +$15.1K 0.02% 1030
2018
Q1 		$2.01M Buy
30,004
+770
+3% +$43.9K 0.01% 1224
2017
Q4 		$1.6M Sell
29,234
-760
-3% -$40.1K 0.01% 1405
2017
Q3 		$1.44M Buy
29,994
+605
+2% +$32K 0.01% 1420
2017
Q2 		$1.73M Sell
29,389
-1,520
-5% -$88.5K 0.01% 1287
2017
Q1 		$1.67M Buy
30,909
+1,258
+4% +$60K 0.01% 1341
2016
Q4 		$1.3M Buy
29,651
+1,613
+6% +$68.6K 0.01% 1468
2016
Q3 		$1.29M Sell
28,038
-6
-0% -$299 0.01% 1363
2016
Q2 		$1.39M Sell
28,044
-699
-2% -$35.3K 0.01% 1304
2016
Q1 		$1.41M Buy
28,743
+66
+0.2% +$2.55K 0.01% 1283
2015
Q4 		$1.09M Buy
28,677
+71
+0.2% +$2.84K 0.01% 1353
2015
Q3 		$1.09M Sell
28,606
-39,430
-58% -$1.66M 0.01% 1394
2015
Q2 		$2.7M Buy
68,036
+34,824
+105% +$1.09M 0.01% 1344
2015
Q1 		$889K Sell
33,212
-31,382
-49% -$885K 0.01% 1550
2014
Q4 		$1.9M Buy
64,594
+32,133
+99% +$793K 0.01% 1513
2014
Q3 		$655K Buy
32,461
+198
+0.6% +$3.82K 0.01% 1662
2014
Q2 		$540K Sell
32,263
-100
-0.3% -$1.42K ﹤0.01% 1770
2014
Q1 		$482K Sell
32,363
-1,000
-3% -$15.4K ﹤0.01% 1881
2013
Q4 		$488K Sell
33,363
-1,623
-5% -$26.1K ﹤0.01% 1877
2013
Q3 		$602K Buy
34,986
+1,688
+5% +$25K ﹤0.01% 1919
2013
Q2 		$386K Buy
+33,298
New +$381K ﹤0.01% 1838

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Comerica Bank's AMED Position: Q3 2025 in Review

Comerica Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 9,202 shares — an estimated $905K sold.

Comerica Bank first reported a position in AMED in Q2 2013 and held it in 48 quarters. The position peaked at $7.2M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Comerica Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Comerica Bank sold 9,202 Amedisys shares in Q3 2025, an estimated $905K.
  • Comerica Bank first reported a position in Amedisys in Q2 2013 and held it in 48 quarters.
  • Comerica Bank's Amedisys position peaked at $7.2M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Comerica Bank's 13F filing for Q3 2025, filed 14 Nov 2025.